Jane Metrik1,2, Rachel L Gunn1, Kristina M Jackson1, Alexander W Sokolovsky1, Brian Borsari3,4. 1. Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, Rhode Island. 2. Providence VA Medical Center, Providence, Rhode Island. 3. San Francisco VA Health Care System, San Francisco, California. 4. Department of Psychiatry, University of California - San Francisco, San Francisco, California.
Abstract
BACKGROUND: The study aims were to examine daily associations between marijuana and alcohol use and the extent to which the association differs as a function of cannabis use disorder (CUD) and/or alcohol use disorder (AUD) diagnosis. METHODS: Timeline Followback interview data was collected in a study of veterans (N = 127) recruited from a Veterans Affairs hospital who reported at least 1 day of co-use of marijuana and alcohol in the past 180 days (22,860 observations). Participants reported 40% marijuana use days, 28% drinking days, with 37% meeting DSM-5 criteria for CUD, 40% for AUD, and 15% for both. Use of marijuana on a given day was used to predict a 3-level gender-adjusted drinking variable (heavy: ≥5 (men)/4 (women) drinks; moderate: 1 to 4/3 drinks; or none: 0 drinks). A categorical 4-level variable (no diagnosis, AUD, CUD, or both) was tested as a moderator of the marijuana-alcohol relationship. RESULTS: Multilevel modeling analyses demonstrated that participants were more likely to drink heavily compared to moderately (OR = 2.34) and moderately compared to not drinking (OR = 1.61) on marijuana use days relative to nonuse days. On marijuana use days, those with AUD and those with AUD + CUD were more likely to drink heavily (OR = 1.91; OR = 2.51, respectively), but those with CUD were less likely to drink heavily (OR = 0.32) compared to moderately, nonsignificant differences between any versus moderate drinking in interaction models. CONCLUSIONS: Heavy drinking occurs on days when marijuana is also used. This association is particularly evident in individuals diagnosed with both AUD and CUD and AUDs alone but not in those with only CUDs. Findings suggest that alcohol interventions may need to specifically address marijuana use as a risk factor for heavy drinking and AUD.
BACKGROUND: The study aims were to examine daily associations between marijuana and alcohol use and the extent to which the association differs as a function of cannabis use disorder (CUD) and/or alcohol use disorder (AUD) diagnosis. METHODS: Timeline Followback interview data was collected in a study of veterans (N = 127) recruited from a Veterans Affairs hospital who reported at least 1 day of co-use of marijuana and alcohol in the past 180 days (22,860 observations). Participants reported 40% marijuana use days, 28% drinking days, with 37% meeting DSM-5 criteria for CUD, 40% for AUD, and 15% for both. Use of marijuana on a given day was used to predict a 3-level gender-adjusted drinking variable (heavy: ≥5 (men)/4 (women) drinks; moderate: 1 to 4/3 drinks; or none: 0 drinks). A categorical 4-level variable (no diagnosis, AUD, CUD, or both) was tested as a moderator of the marijuana-alcohol relationship. RESULTS: Multilevel modeling analyses demonstrated that participants were more likely to drink heavily compared to moderately (OR = 2.34) and moderately compared to not drinking (OR = 1.61) on marijuana use days relative to nonuse days. On marijuana use days, those with AUD and those with AUD + CUD were more likely to drink heavily (OR = 1.91; OR = 2.51, respectively), but those with CUD were less likely to drink heavily (OR = 0.32) compared to moderately, nonsignificant differences between any versus moderate drinking in interaction models. CONCLUSIONS: Heavy drinking occurs on days when marijuana is also used. This association is particularly evident in individuals diagnosed with both AUD and CUD and AUDs alone but not in those with only CUDs. Findings suggest that alcohol interventions may need to specifically address marijuana use as a risk factor for heavy drinking and AUD.
Authors: Zach Walsh; Robert Callaway; Lynne Belle-Isle; Rielle Capler; Robert Kay; Philippe Lucas; Susan Holtzman Journal: Int J Drug Policy Date: 2013-09-09
Authors: Johannes G Ramaekers; Eef L Theunissen; Marjolein de Brouwer; Stefan W Toennes; Manfred R Moeller; Gerhold Kauert Journal: Psychopharmacology (Berl) Date: 2010-10-30 Impact factor: 4.530
Authors: Vanessa Morris; Herry Patel; Lana Vedelago; Derek D Reed; Jane Metrik; Elizabeth Aston; James MacKillop; Michael Amlung Journal: J Stud Alcohol Drugs Date: 2018-11 Impact factor: 2.582
Authors: Christine M Lee; Megan E Patrick; Charles B Fleming; Jennifer M Cadigan; Devon A Abdallah; Anne M Fairlie; Mary E Larimer Journal: Alcohol Clin Exp Res Date: 2020-02-05 Impact factor: 3.455
Authors: Kristina L Bailey; Todd A Wyatt; Dawn M Katafiasz; Keenan W Taylor; Art J Heires; Joseph H Sisson; Debra J Romberger; Ellen L Burnham Journal: Alcohol Date: 2018-11-10 Impact factor: 2.405
Authors: Rachel L Gunn; Alyssa L Norris; Alexander Sokolovsky; Lauren Micalizzi; Jennifer E Merrill; Nancy P Barnett Journal: Psychol Addict Behav Date: 2018-10-25
Authors: Alexa J Pellegrino; Kerry D Duck; Dylan P J Kriescher; Mackenzie E Shrake; Michael M Phillips; Trent L Lalonde; Kristina T Phillips Journal: J Drug Issues Date: 2020-07-04
Authors: Elizabeth J D'Amico; Anthony Rodriguez; Joan S Tucker; Michael S Dunbar; Eric R Pedersen; Regina A Shih; Jordan P Davis; Rachana Seelam Journal: Prev Sci Date: 2020-05